REG4 and exocrine pancreatic carcinoma: IHC analysis has confirmed RegIV expression in gastric, colorectal, and pancreatic carcinoma [27], [37], [38], and that RegIV has a potential role in diagnosing digestive tract neuroendocrine tumors [39].